Methotrexate-triggered ferroptosis suppresses oral cancer progression by phosphorylated KEAP1-mediated NRF2 degradation to inhibit SLC7A11/GPX4 signaling pathway
Open Access
- 6 January 2026
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 26 (1)
Abstract
Oral cancer (OC) is the most common type of head and neck cancer, with a high mortality rate, and is a leading cause of cancer-related deaths worldwide. DrKeywords
Funding Information
- The Special Research Fund Project in Clinical Medicine of Nantong University (2024JZ024)
- The Scientific Research Program of Nantong (JC2024105)
- National Natural Science Foundation of China (81903154)
- China Postdoctoral Science Foundation (2022M711722)
This publication has 42 references indexed in Scilit:
- Recent advances of photodiagnosis and treatment for head and neck squamous cell carcinomaNeoplasia, 2024
- Chronotherapy in head and neck cancer: A systematic review and meta‐analysisInternational Journal of Cancer, 2024
- Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinomaCancer Letters, 2024
- The crosstalk between oncogenic signaling and ferroptosis in cancerCritical Reviews in Oncology/Hematology, 2024
- The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventionsCancer Cell, 2024
- Cell deathCell, 2024
- Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled TrialArthritis & Rheumatology, 2024
- Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrenceOral Oncology, 2023
- Methotrexate in early rheumatoid arthritis: Is the anchor drug still holding?Autoimmunity Reviews, 2022
- Side effects of methotrexate therapy for rheumatoid arthritis: A systematic reviewEuropean Journal of Medicinal Chemistry, 2018